BPIQ Blog

Upcoming Pegozafermin NASH Readout!

Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...

Feb 22, 20233 min read

$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...

Jun 27, 20222 min read

$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...

Jun 27, 20222 min read

Updated 6/27/22 Summary The International Liver Congress (ILC) 2022 is taking place from June 22 - 26 in-person at ExCeL in London and...

Jun 17, 20225 min read

At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...

May 18, 20221 min read

Our platform helps you uncover your next biotech investment opportunity